Affiliations 

  • 1 Department of Applied Cybernetics, Faculty of Science, University of Hradec Králové, Hradec Králové 50003, Czech Republic. Electronic address: venkatachalam.k@ieee.org
  • 2 University of Belgrade, Faculty of Transport and Traffic Engineering, Vojvode Stepe 305, 11010 Belgrade, Serbia; Yuan Ze University, College of Engineering, Department of Industrial Engineering and Management, Taoyuan City 320315, Taiwan; Department of Computer Science and Engineering, College of Informatics, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Republic of Korea. Electronic address: vsima@sf.bg.ac.rs
  • 3 Faculty of Informatics and Computing, Singidunum University, Danijelova 32, 11000 Belgrade, Serbia; Department of Mathematics, Saveetha School of Engineering, SIMATS, Thandalam, Chennai, 602105, Tamilnadu, India; MEU Research Unit, Middle East University, Amman, Jordan; Sinergija University, Raje Banjičića, Bijeljina 76300, Bosnia and Herzegovina. Electronic address: nbacanin@singidunum.ac.rs
  • 4 Department of Operations Research and Statistics, Faculty of Organizational Sciences, University of Belgrade, Belgrade, Serbia; Department of Mechanics and Mathematics, Western Caspian University, Baku, Azerbaijan; School of Engineering and Technology, Sunway University, Selangor, Malaysia. Electronic address: dragan.pamucar@fon.bg.ac.rs
Neural Netw, 2025 Jan;181:106822.
PMID: 39490023 DOI: 10.1016/j.neunet.2024.106822

Abstract

Radiologists utilize pictures from X-rays, magnetic resonance imaging, or computed tomography scans to diagnose bone cancer. Manual methods are labor-intensive and may need specialized knowledge. As a result, creating an automated process for distinguishing between malignant and healthy bone is essential. Bones that have cancer have a different texture than bones in unaffected areas. Diagnosing hematological illnesses relies on correct labeling and categorizing nucleated cells in the bone marrow. However, timely diagnosis and treatment are hampered by pathologists' need to identify specimens, which can be sensitive and time-consuming manually. Humanity's ability to evaluate and identify these more complicated illnesses has significantly been bolstered by the development of artificial intelligence, particularly machine, and deep learning. Conversely, much research and development is needed to enhance cancer cell identification-and lower false alarm rates. We built a deep learning model for morphological analysis to solve this problem. This paper introduces a novel deep convolutional neural network architecture in which hybrid multi-objective and category-based optimization algorithms are used to optimize the hyperparameters adaptively. Using the processed cell pictures as input, the proposed model is then trained with an optimized attention-based multi-scale convolutional neural network to identify the kind of cancer cells in the bone marrow. Extensive experiments are run on publicly available datasets, with the results being measured and evaluated using a wide range of performance indicators. In contrast to deep learning models that have already been trained, the total accuracy of 99.7% was determined to be superior.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.